Search for:

The Cancer Letter on Facebook
The Cancer Letter on Twitter
The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home

About
Current Issue
- Past Issues
Podcast
- The Directors
Events
Job Board

Search for:

Home

About
Current Issue
- Past Issues
Podcast
- The Directors
Events
Job Board

Trials & Tribulations

Free Trials & Tribulations

Cabozantinib in first-line treatment of metastatic renal cell carcinoma

January 05, 2018

Vol.44 No.01

By Tian Zhang, Michael J. Morris, Darren R. Feldman, Toni K. Choueiri and Daniel J. George

Posts navigation

Previous 1…1314

Trending Stories

As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded
Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”
Peter F. Garrett to people with cancer: Your story has power
Lessons from the AIDS Quilt: what the cancer world can learn from AIDS advocacy
Survivorship begins at diagnosis—cancer care system must recognize this
House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget

ABOUT

About The Cancer Letter

Accessibility Statement

SUBSCRIPTIONS

CONTACT

Submission guidelines

Advertise

Careers

SEE ALSO

Terms & Conditions

Scroll to top

Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

SEARCH DATE

SEARCH TEXT

Cancel

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

Password

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Username or Email

Password

Remember Me Forgot Password?

Site license subscribers:
Log in with your IP | Register a sponsored account